Published in

Sociedade Brasileira de Hematologia e Hemoterapia, Revista Brasileira de Hematologia e Hemoterapia, 1(27), 2005

DOI: 10.1590/s1516-84842005000100018

Links

Tools

Export citation

Search in Google Scholar

Translocation t(1;16) in Chronic Eosinophilic Leukaemia

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

Translocation t(1;16) in Chronic Eosinophilic Leukaemia Translocação t(1;16) em Leucemia Eosinofílica Crônica leukocytosis with eosinophilia. At this time the peripheral blood examination showed: Hb: 15.2g/dl, WBC: 23.7x10 3 /µl (1% myelocytes, 3% metamyelocytes, 38% neutrophils, 45% eosinophils, 5% basophils, 6% lymphocytes and 2% of monocytes) and Platelets: 121.0x10 3 /µL. Infiltration by mature Eo was seen by histological examination of a skin lesion. Bone marrow aspirate showed hypercellularity of the granulocytic lineage with 45% of mature Eo. The diagnosis of CEL was based on a blood sample and bone marrow aspirate and biopsy analysis using conventional criteria. 4 The BCR-ABL transcript was negative by the conventional method of molecular analysis. 5 The bone marrow cells were cultured for obtaining karyotype according to a conventional method. 6 The karyotype 47,XX,der(16)(16q22+),+21 was identified in all analysed metaphases (Figure 1). The t(1;16) was seen in all metaphases analysed by fluorescence in situ hybridisation (FISH), using a painting probe for chromosome 1 (WPC DNA Probe 1, Spectrum Orange) obtained from Vysis (Downers Grove IL, USA) (Fi-gure 2). The patient has been seen in our service for four years, under hydroxyurea (500 mg daily) therapy, without symptoms or transformation to a blastic crisis. The t(1;16) is a frequent recurrent rearrangement in solid tumours such as breast carcinoma and Ewing's sarcoma, 7 but it has very occasionally been described in haematological malignancies. 8,9 To the best of our knowledge, this chromosomal abnormality has not yet been described in CEL. The gene CBFB is located in the 16q22 region and is implicated in the abnormal eosinophilopoiesis observed in acute myelomonocytic leukaemia with eosinophilia (M4Eo). 10 Thus, we hypothesize that the same gene could have been involved in the origin of the patient's CEL disease. Chronic eosinophilic leukaemia (CEL) is a rare myeloproliferative disease in which clonal proliferation of eosinophil (Eo) precursors results in persistent increase of mature Eo in the bone marrow and peripheral blood. 1 Various chromosomal abnormalities have been reported in CEL, 2 especially aberrations of the long arm of the chromosome 5, involving breakpoints in the q31-35 region, where genes encoding for interleukin-3, interleukin-5, granulocyte macrophage-colony stimulating factor and platelet-derived growth factor β receptor are located. 3 We present herein a case of CEL that presented a der(16)t(1;16). The patient was a 60-year-old female first referred to our unit in November 2000 due to skin lesions and